Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

vGRID SBRT: A Phase I Clinical Trial in Unresectable or Metastatic HCC

NCT05727787 is registered in ClinicalTrials.gov with University of Kansas Medical Center as lead sponsor.

NCT NCT05727787
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05727787 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
vGRID SBRT: A Phase I Clinical Trial in Unresectable or Metastatic HCC
Lead sponsor
University of Kansas Medical Center
Phase
Not applicable
Overall status
Recruiting
Start date
February 23, 2023
Completion date
August 31, 2028
Enrollment
18 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

liver cancer